Patient-Centered Chronic Kidney Disease Care
CKD affects 37M US adults in the US and costs Medicare $120B dollars to treat each year. The progression through the five stages of CKD can be delayed, but cannot be reversed.
In order to improve outcomes and save on costs associated with CKD and ESRD, several challenges with care must be addressed. Ultimately, treatments must be made more patient-centric.
In this white paper, we will be discussing:
Challenges leading to increased costs and poor outcomes for CKD individuals
- Startups that are working to alleviate the challenges
- Investment recommendations for the CKD market